Corporate News – Aveanna Healthcare Holdings Inc.
Stock performance
At 05:39 PM Central Europe on Friday 23 Oct 2026, Aveanna Healthcare (AVAH) closed 1.88 % higher.
Current trading price: USD 13.32.
Outstanding shares: 218.2 million.
Market capitalization: USD 2.8 billion.
Trading volume in the last 24 hours: USD 36.1 million.
Since the end of the previous month, the share price has declined 1.74 %.
200‑day simple moving average: USD 9.08.
52‑week high: USD 14.71 (16 Sep 2026).
52‑week low: USD 5.93 (19 Mar 2026).
Upcoming corporate events
Aveanna will release its third‑quarter 2026 earnings report before the market opens on Thursday, 12 Nov 2026.
A conference call to discuss the results will be held later that day and will be available by telephone and webcast.
A replay will be provided for one week after the call.
Business overview
Headquartered in Atlanta, Aveanna offers pediatric and adult health‑care services nationwide, including nursing, rehabilitation, therapy, home‑health support, case‑management, and respite care.
The announcement reinforces the company’s commitment to transparent financial reporting and investor communication.
Related Stock Performance (Last 24 Hours)
| Ticker | Direction | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|
| MGNI (Magnite) | Down 2.07 % | 23.04 | 3.4 bn | 22.61 |
| FA (First Advantage) | Up 0.51 % | 21.20 | 3.4 bn | 135.79 |
| MIAX (Miami) | Up 3.61 % | 34.03 | 3.3 bn | – |
| AAMI (Acadian Asset Management) | Up 0.79 % | 92.38 | 3.4 bn | 33.49 |
| VKTX (Viking Therapeutics) | Down 2.08 % | 24.87 | 3.4 bn | – |
Additional Notes on First Advantage (FA)
- On 22 Oct 2026, First Advantage filed a Form 4 with the SEC indicating that Global COO Nairne Douglas purchased approximately 7,000 shares of common stock, now holding about 54,000 shares.
- Douglas also exercised 7,000 restricted stock units that vested on the same day, converting them into common shares.
- No further corporate actions or material events were disclosed in the filing.
Additional Notes on Viking Therapeutics (VKTX)
- Viking will release its third‑quarter 2026 financial results after market close on 28 Oct 2026, with a conference call scheduled for 4:30 p.m. Eastern Time.
- The call will be accessible by telephone and webcast.
- Viking is a clinical‑stage biopharmaceutical firm focusing on metabolic and endocrine disorders, advancing therapies such as VK2735.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc. operates in the United States, with its main base in Atlanta. The company and its subsidiaries provide pediatric and adult home‑care services, including pediatric therapy, adult skilled nursing, and medical solutions tailored to patient needs.